Clinical and dosimetric considerations for Y90

recommendations from an international multidisciplinary working group

Riad Salem*, Siddharth A. Padia, Marnix Lam, Jon Bell, Carlo Chiesa, Kirk Fowers, Bonnie Hamilton, Joseph Herman, S. Cheenu Kappadath, Thomas Leung, Lorraine Portelance, Daniel Sze, Etienne Garin

*Corresponding author for this work

Research output: Contribution to journalArticle

Abstract

The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.

Original languageEnglish (US)
Pages (from-to)1695-1704
Number of pages10
JournalEuropean Journal of Nuclear Medicine and Molecular Imaging
Volume46
Issue number8
DOIs
StatePublished - Jul 1 2019

Fingerprint

Microspheres
Glass
Radiometry
Health Personnel
Hepatocellular Carcinoma
Radiotherapy
Liver
Neoplasms

Keywords

  • Hepatocellular carcinoma
  • Liver cancer
  • Radioembolization
  • Yttrium-90

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Salem, Riad ; Padia, Siddharth A. ; Lam, Marnix ; Bell, Jon ; Chiesa, Carlo ; Fowers, Kirk ; Hamilton, Bonnie ; Herman, Joseph ; Kappadath, S. Cheenu ; Leung, Thomas ; Portelance, Lorraine ; Sze, Daniel ; Garin, Etienne. / Clinical and dosimetric considerations for Y90 : recommendations from an international multidisciplinary working group. In: European Journal of Nuclear Medicine and Molecular Imaging. 2019 ; Vol. 46, No. 8. pp. 1695-1704.
@article{9bc24e5d10ea4c2e9c06d2c80e0ceb8e,
title = "Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group",
abstract = "The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.",
keywords = "Hepatocellular carcinoma, Liver cancer, Radioembolization, Yttrium-90",
author = "Riad Salem and Padia, {Siddharth A.} and Marnix Lam and Jon Bell and Carlo Chiesa and Kirk Fowers and Bonnie Hamilton and Joseph Herman and Kappadath, {S. Cheenu} and Thomas Leung and Lorraine Portelance and Daniel Sze and Etienne Garin",
year = "2019",
month = "7",
day = "1",
doi = "10.1007/s00259-019-04340-5",
language = "English (US)",
volume = "46",
pages = "1695--1704",
journal = "European Journal Of Nuclear Medicine",
issn = "0340-6997",
publisher = "Springer Verlag",
number = "8",

}

Salem, R, Padia, SA, Lam, M, Bell, J, Chiesa, C, Fowers, K, Hamilton, B, Herman, J, Kappadath, SC, Leung, T, Portelance, L, Sze, D & Garin, E 2019, 'Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group', European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 8, pp. 1695-1704. https://doi.org/10.1007/s00259-019-04340-5

Clinical and dosimetric considerations for Y90 : recommendations from an international multidisciplinary working group. / Salem, Riad; Padia, Siddharth A.; Lam, Marnix; Bell, Jon; Chiesa, Carlo; Fowers, Kirk; Hamilton, Bonnie; Herman, Joseph; Kappadath, S. Cheenu; Leung, Thomas; Portelance, Lorraine; Sze, Daniel; Garin, Etienne.

In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 46, No. 8, 01.07.2019, p. 1695-1704.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical and dosimetric considerations for Y90

T2 - recommendations from an international multidisciplinary working group

AU - Salem, Riad

AU - Padia, Siddharth A.

AU - Lam, Marnix

AU - Bell, Jon

AU - Chiesa, Carlo

AU - Fowers, Kirk

AU - Hamilton, Bonnie

AU - Herman, Joseph

AU - Kappadath, S. Cheenu

AU - Leung, Thomas

AU - Portelance, Lorraine

AU - Sze, Daniel

AU - Garin, Etienne

PY - 2019/7/1

Y1 - 2019/7/1

N2 - The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.

AB - The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by BTG International to review existing data and address gaps in knowledge related to dosimetry. This committee is comprised of health care providers with diverse areas of expertise and perspectives on radiation dosimetry. The goal of these recommendations is to optimize glass microspheres radiation therapy for hepatocellular carcinoma while accounting for variables including disease presentation, tumour vascularity, liver function, and curative/palliative intent. The recommendations aim to unify glass microsphere users behind standardized dosimetry methodology that is simple, reproducible and supported by clinical data, with the overarching goal of improving clinical outcomes and advancing the knowledge of dosimetry.

KW - Hepatocellular carcinoma

KW - Liver cancer

KW - Radioembolization

KW - Yttrium-90

UR - http://www.scopus.com/inward/record.url?scp=85066012938&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066012938&partnerID=8YFLogxK

U2 - 10.1007/s00259-019-04340-5

DO - 10.1007/s00259-019-04340-5

M3 - Article

VL - 46

SP - 1695

EP - 1704

JO - European Journal Of Nuclear Medicine

JF - European Journal Of Nuclear Medicine

SN - 0340-6997

IS - 8

ER -